NVO Novo Nordisk Earnings and EPS analysis

EPS in 2026 (TTM): 27.45 DKK

Last Report Period Date: Mar 31, 2026

Currently, NVO's 12-month EPS stands at 27.45 DKK, according to the most recent financial reports. Novo Nordisk's earnings per share in 2025 was reported at 23.06 DKK, marking a rise from 22.67 DKK in 2024. NVO recorded an EPS of 10.93 DKK for the quarterly period ending on Mar 31, 2026.

In 2025, Novo Nordisk's earnings per share was 23.06 DKK, a rise of 1.7% from 22.67 DKK in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was 10.93 DKK, showing a 67.1% increase compared to the same quarter last year. The trailing twelve months EPS for NVO is 27.45 DKK as of March 2026. Novo Nordisk's full-year EPS for 2024 was 22.67 DKK, a 21.4% rise compared to the previous year.

Novo Nordisk has recorded a growth in earnings per share of 67.1% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 23.4% per year. Novo Nordisk had an average annual EPS growth of 20.7% in the last five years. When assessed over a ten-year period, NVO's average EPS annual growth was 13%.